Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126003913 | 12600391 | 3 | F | 2016 | 20160902 | 20160727 | 20160908 | EXP | HU-SYMPLMED PHARMACEUTICALS-2016SYMPLMED000279 | SYMPLMED PHARMACEUTICALS | 0.00 | Y | 0.00000 | 20160908 | OT | HU | HU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126003913 | 12600391 | 1 | PS | Covercard | AMLODIPINE BESYLATEPERINDOPRIL ARGININE | 1 | Oral | 1 (10MG/5MG) TABLET, QD | UNKNOWN | 205003 | TABLET | ||||||||
| 126003913 | 12600391 | 2 | SS | Covercard | AMLODIPINE BESYLATEPERINDOPRIL ARGININE | 1 | Oral | 1 (10MG/5MG) TABLET, QD | UNKNOWN | 205003 | TABLET | ||||||||
| 126003913 | 12600391 | 3 | SS | Coverex-AS | PERINDOPRIL ARGININE | 1 | Oral | 10 MG, QD | UNKNOWN | 0 | 10 | MG | TABLET | ||||||
| 126003913 | 12600391 | 4 | SS | COVERCARD PLUS | AMLODIPINE BESYLATEINDAPAMIDEPERINDOPRIL ARGININE | 1 | Oral | 1 DF, QD | N | U | UNKNOWN | 0 | 1 | DF | TABLET | ||||
| 126003913 | 12600391 | 5 | SS | CARDURA XL | DOXAZOSIN MESYLATE | 1 | Unknown | 4 MG, QD | N | U | UNKNOWN | 0 | 4 | MG | |||||
| 126003913 | 12600391 | 6 | C | AFLAMIN /01140001/ | 2 | 100 MG, PRN | U | UNKNOWN | 0 | 100 | MG | ||||||||
| 126003913 | 12600391 | 7 | C | RIVOTRIL | CLONAZEPAM | 1 | 0.5 MG, PRN | U | UNKNOWN | 0 | .5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126003913 | 12600391 | 1 | Hypertension |
| 126003913 | 12600391 | 3 | Hypertension |
| 126003913 | 12600391 | 4 | Hypertension |
| 126003913 | 12600391 | 5 | Hypertension |
| 126003913 | 12600391 | 6 | Arthritis |
| 126003913 | 12600391 | 7 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126003913 | 12600391 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126003913 | 12600391 | Abdominal distension | |
| 126003913 | 12600391 | Alopecia | |
| 126003913 | 12600391 | Arthralgia | |
| 126003913 | 12600391 | Blepharitis | |
| 126003913 | 12600391 | Constipation | |
| 126003913 | 12600391 | Dizziness | |
| 126003913 | 12600391 | Gingivitis | |
| 126003913 | 12600391 | Headache | |
| 126003913 | 12600391 | Hyperhidrosis | |
| 126003913 | 12600391 | Inflammation of lacrimal passage | |
| 126003913 | 12600391 | Oedema peripheral | |
| 126003913 | 12600391 | Oropharyngeal pain | |
| 126003913 | 12600391 | Pain in extremity | |
| 126003913 | 12600391 | Paraesthesia | |
| 126003913 | 12600391 | Prescribed overdose | |
| 126003913 | 12600391 | Product use issue | |
| 126003913 | 12600391 | Slow speech | |
| 126003913 | 12600391 | Therapeutic response decreased | |
| 126003913 | 12600391 | Urinary incontinence | |
| 126003913 | 12600391 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126003913 | 12600391 | 1 | 20160512 | 0 | ||
| 126003913 | 12600391 | 4 | 20160513 | 0 | ||
| 126003913 | 12600391 | 5 | 20160513 | 0 | ||
| 126003913 | 12600391 | 7 | 2008 | 0 |